Bridge Biotherapeutics acquires new candidate for back-eye diseases
Drug Discovery | News | 0 Comment | 06 Feb, 2020
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, Republic of Korea has acquired ...Read more
Astellas submits sNDA in Japan for Evrenzo to treat Anemia
Drug Discovery | News | 0 Comment | 30 Jan, 2020
Astellas Pharma Inc. and FibroGen, Inc. has announced the submission of a supplemental New Drug Application (sNDA) to&nb...Read more
Noxopharm to transform cancer treatment space
Drug Discovery | News | 0 Comment | 29 Jan, 2020
Headquartered in Australia, Noxopharm Limited is a clinical stage drug development company that has been in the limeligh...Read more
PerkinElmer unveils Advanced Drug Discovery and Disease Research Solutions
Drug Discovery | News | 0 Comment | 28 Jan, 2020
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, introduced new workstations...Read more
CEPI selects Inovio to develop vaccine against coronavirus
Drug Discovery | News | 0 Comment | 28 Jan, 2020
US based Inovio Pharmaceuticals, has announced the Coalition for Epidemic Preparedness Innovations (CEPI) has awarded In...Read more
Darolutamide gets marketing authorization in Japan
Drug Discovery | News | 0 Comment | 24 Jan, 2020
The Japanese Ministry of Health, Labor and Welfare (MHLW) has granted marketing authorization for darolutamide, under th...Read more
RegeneRx Biopharma receives patent in Korea
Drug Discovery | News | 0 Comment | 23 Jan, 2020
US based RegeneRx Biopharmaceuticals, a clinical-stage drug development company focused on tissue protection, repai...Read more
Hitachi Chemical inks pact with Ori Biotech
Drug Discovery | News | 0 Comment | 23 Jan, 2020
Hitachi Chemical Advanced Therapeutics Solutions, LLC, a US subsidiary of Japanese firm Hitachi Chemical Co., Ltd....Read more
PhoreMost, Otsuka collaborate for multi drug discovery projects
Drug Discovery | News | 0 Comment | 22 Jan, 2020
PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease target...Read more
ViiV Healthcare wins Japanese approval for Dovato to treat HIV-1
Drug Discovery | News | 0 Comment | 20 Jan, 2020
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as share...Read more
InterVenn Biosciences advances glycoproteomics for complex disease therapies
Drug Discovery | News | 0 Comment | 17 Jan, 2020
US based InterVenn Biosciences has announced multiple achievements in its development of AI-enabled glycoproteomics, as ...Read more
Charles River inks scientific collaboration with Takeda
Drug Discovery | News | 0 Comment | 16 Jan, 2020
US based company Charles River has announced a multi-year drug discovery collaboration with Japanese firm Takeda Pharmac...Read more
Hitachi starts commercial manufacturing of Zynteglo
Drug Discovery | News | 0 Comment | 15 Jan, 2020
apceth Biopharma GmbH, a subsidiary of Japan headquartered Hitachi Chemical Co., Ltd. and a leading company for the manu...Read more
FDA approves sNDA for Astellas’s antifungal drug
Drug Discovery | News | 0 Comment | 13 Jan, 2020
Japan based Astellas Pharma Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its supplem...Read more
China approves AstraZeneca’s Lokelma to treat hyperkalaemia
Drug Discovery | News | 0 Comment | 07 Jan, 2020
AstraZeneca’s Lokelma (sodium zirconium cyclosilicate) has been approved in China for the treatment of a...Read more
China grants priority review to Luye Pharma's schizophrenia drug
Drug Discovery | News | 0 Comment | 02 Jan, 2020
Luye Pharma Group has announced that the New Drug Application (NDA) for Risperidone Extended-Release Microspheres for In...Read more
AstraZeneca’s triple-combination therapy gets approval in China for COPD
Drug Discovery | News | 0 Comment | 01 Jan, 2020
AstraZeneca has announced that budesonide/glycopyrronium/formoterol fumarate has been approved in China for the maintena...Read more
Luye Pharma seeks USFDA approval for antidepressant drug
Drug Discovery | News | 0 Comment | 30 Dec, 2019
China based Luye Pharma Group has announced submission of a new drug application (NDA) to the U.S. Food and Drug Adminis...Read more